Shenzhen New Industries Biomedical Engineering Co., Ltd.

Shenzhen New Industries Biomedical Engineering Co., Ltd. (Briefed as SNIBE) located in Science & Industry Park, Nanshan District, Shenzhen, China, was founded in December 1995 with a registered capital of CNY 106,000,000. SNIBE is a bio-medical company specialized in clinical laboratory instruments and in-vitro diagnosti ...
Productos Covid-19
Close

Covid-19 Shenzhen New Industries Biomedical Engineering Co., Ltd.

Laboratorio clínico

SARS-CoV-2 Test
Molecision SARS-CoV-2 RT-PCR Assay

The Molecision SARS-CoV-2 RT-PCR Assay is a real time reverse transcriptase (RT) polymerase chain reaction (PCR) used for the qualitative detection of SARS-CoV-2 from nasal, oropharyngeal, nasopharyngeal swabs and BALF (bronchoalveolar lavage fluid) of suspected cases of COVID-19. The dual target assay with three target primers for detecting ORF1ab and N genes is also available as a CE-IVD test for countries accepting the CE-mark.
Mas detalles

SARS-CoV-2 Antibody Test
MAGLUMI SARS-CoV-2 S-RBD IgG

The MAGLUMI SARS-CoV-2 S-RBD IgG is designed for the quantitative detection of antibodies to the receptor-binding domain of the S protein and has 99.6% specificity and 100% sensitivity at 15 days post-onset of symptom for COVID-19, which can provide more accurate and reasonable results. The test can be run on MAGLUMI CLIA systems, including the MAGLUMI X8 immunoassay analyzer, and provides results within 30 minutes using only 10uL sample volume.
Mas detalles

SARS-CoV2 Antibody Test
MAGLUMI 2019-nCoV (SARS-CoV-2) IgM/IgG kits

The MAGLUMI 2019-nCoV (SARS-CoV-2) IgM/IgG kits are the world's first CE Marked CLIA antibody assay for COVID-19 and offer a joint detection solution (IgG+IgM) for SARS-CoV-2 to ensure high clinical sensitivity. As the world's fastest fully automated CLIA solution (high throughput and sensitivity method), the kits enable antibody detection with numerical results using only 10μL sample volume and offers rapid detection within 30 minutes (analyzer model dependent).
Mas detalles
Facebook Twitter Google+ Linked in

Prenatal Screening Risk Calculation Software

Modelo: Preaccu
Prenatal Screening Risk Calculation Software

Descripción:

The Preaccu prenatal screening risk calculation software is suitable for prenatal screening of Trisomy 21 (Down syndrome), Trisomy 18/13 (Edwards syndrome, Patau syndrome) and neural-tube defects (NTD).

Características: Especificaciones:

Características:

The prenatal screening software is suitable for prenatal screening of Trisomy 21 (Down syndrome), Trisomy 18/13 (Edwards syndrome, Patau syndrome) and neural-tube defects (NTD).

Especificaciones:

Multi-function module
● Risk calculation module
● Truncate value, reference range setting module
●Case data query, export module
●Screening conclusions personalization module
●Report set up module
●Permission control module

Support a variety of screening indicators
●free-β-HCG
●PAPP-A
●AFP
●HCG
●free Estriol (uE3)
●NT Solicite información

Enviar un mensaje al proveedor

* Información requerida
* Email:
Para
Shenzhen New Industries Biomedical Engineering Co., Ltd. ()
* Mensaje

Derecho de autor © 2000-2021 TradeMed.com. Todos los derechos reservados. | Términos y condiciones